Trial Profile
An exploratory study to evaluate the response of salmeterol plus fluticasone propionate vs [versus] fluticasone propionate alone to experimental nasal inoculation with rhinovirus.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary) ; Fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 24 Mar 2009 Actual patient number (16) added as reported by ClinicalTrials.gov.
- 24 Mar 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 27 Oct 2008 Actual end date changed from May 2008 to Jul 2008 as reported by Clinicaltrials.gov.